Hydrocephalus Shunts Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

Pages: 0 Published: April 26, 2022 Report Code: GDME562MM

Hydrocephalus Shunts Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Neurology Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Hydrocephalus Shunts market for the year 2020 and beyond. Surgical treatment of hydrocephalus with a Cerebrospinal Fluid (CSF) Shunting system is a common neurosurgery procedure performed on both paediatric and adult patients. Shunts allow excess Cerebrospinal Fluid (CSF) to drain to another area of the body. In this segment, shunt valves and shunt catheters are considered.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are –

Currently marketed Hydrocephalus Shunts and evolving competitive landscape –

  • Insightful review of the key industry trends.
  • Annualized total Hydrocephalus Shunts market revenue by segment and market outlooks from 2015-2030.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights –

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Hydrocephalus Shunts market.
  • Competitive dynamics insights and trends provided for Hydrocephalus Shunts market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered – Medtronic plc, Integra LifeSciences Corp, Sophysa SA, B. Braun Melsungen AG, Spiegelberg GmbH & Co KG, Natus Medical Incorporated, Hpbio, Others

Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope of the Hydrocephalus Shunts (Neurology Devices) market model

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Currently marketed hydrocephalus shunts and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total hydrocephalus shunts market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices, and market values by segment.
  • Global, Regional, and Country level market-specific insights include qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for hydrocephalus shunts market.
  • Competitive dynamics insights and trends provided for hydrocephalus shunts market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific MedTech regulatory landscape.

What is the Hydrocephalus Shunts (Neurology Devices) market size during the historical and forecast period?

Hydrocephalus Shunts (Neurology Devices) market, by segment

Hydrocephalus Shunts (Neurology Devices) market, by segment

For more segment insights, download a free report sample

What are the key trends within the Hydrocephalus Shunts (Neurology Devices) market?

GlobalData expects that the US, Canada, and Mexico will experience minor changes in their number of congenital hydrocephalus cases, during the forecast period. Mexico has a smaller hydrocephalus shunting market than the US and Canada, largely due to fewer of its inhabitants being aged 70 and older and, is predicted to experience relatively strong growth in the forecast period, thus driving gains in the Mexican shunting market.

In the UK, the growth of the hydrocephalus shunting market is also being driven by an increase in the use of adjustable versus fixed valves. GlobalData predicts that the fastest growing hydrocephalus shunting markets in Europe are Germany, the UK, Denmark, Ireland, the Netherlands, Sweden, Switzerland, Austria, Norway, and Turkey. This is mostly due to strong anticipated growth in inhabitants aged 80 years and older. Russia and Hungary do not conform to these regional trends, and these markets are expected to experience more modest growth.

For most countries in the Asia-Pacific, the majority of newly diagnosed annual hydrocephalus cases are for acquired, rather than congenital, hydrocephalus. Australia, Japan, and New Zealand all have relatively large elderly populations that augment their current hydrocephalus shunting markets. Moving forward, GlobalData predicts that the growth of these markets, together with those of South Korea and Taiwan, will continue to be bolstered by aging populations.

The South & Central American hydrocephalus shunting markets are driven by alternative factors, compared to most countries in the North America, Europe, and the Asia Pacific regions. In Brazil, Argentina, and Chile, congenital hydrocephalus causes a greater disease burden and as such, these patients constitute a larger proportion of total shunting procedures.

Countries in the Middle East & Africa region tend to have higher congenital hydrocephalus incidence rates and reduced elderly populations, compared to the US and most European countries.

Hydrocephalus Shunts (Neurology Devices) market report scope

Market value (Year – 2021) $425.42 million
Segmentation Adjustable Pressure Valves, Fixed Pressure Valves, Antimicrobial Catheters, and Standard Catheters
Key companies Medtronic plc, Integra LifeSciences Corp, Sophysa SA, B. Braun Melsungen AG, Spiegelberg GmbH & Co KG, Natus Medical Incorporated, Hpbio, Others
Regions covered North America, South & Central America, Europe, Middle East & Africa, Asia-Pacific
Countries covered US, Canada, Mexico, France, Germany, Italy, Spain, United Kingdom, Austria, Belgium, Czech Republic, Denmark, Finland, Greece, Hungary, Ireland, Netherlands, Norway, Poland, Portugal, Russia, Sweden, Switzerland, Turkey, Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Brazil, Chile, Egypt, Israel, Saudi Arabia, South Africa, United Arab Emirates

Who are the Hydrocephalus Shunts market vendors?

The model analyses the competitive landscape of the hydrocephalus shunts market and includes information on the following key market vendors:

Medtronic plc, Integra LifeSciences Corp, Sophysa SA, B. Braun Melsungen AG, Spiegelberg GmbH & Co KG, Natus Medical Incorporated, Hpbio.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –

  • CMO executives who must have deep understanding of the Hydrocephalus Shunts marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to –

  • Understand the impact of COVID-19 on Hydrocephalus Shunts market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Hydrocephalus Shunts market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Hydrocephalus Shunts market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Hydrocephalus Shunts market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Key Players

Medtronic plc

Integra LifeSciences Corp

Sophysa SA

B. Braun Melsungen AG

Spiegelberg GmbH & Co KG

Natus Medical Inc

Hpbio

Others

Frequently Asked Questions

Request a Free Sample
$7500

Can be used by individual purchaser only

$22500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.